Free Trial
NASDAQ:PETQ

PetIQ (PETQ) Stock Price, News & Analysis

$21.89
+0.44 (+2.05%)
(As of 07/26/2024 ET)
Today's Range
$21.73
$22.15
50-Day Range
$19.68
$22.87
52-Week Range
$15.09
$22.98
Volume
191,088 shs
Average Volume
293,141 shs
Market Capitalization
$651.23 million
P/E Ratio
99.50
Dividend Yield
N/A
Price Target
$29.00

PetIQ MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
32.5% Upside
$29.00 Price Target
Short Interest
Bearish
8.15% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.43mentions of PetIQ in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$268,876 Sold Last Quarter
Proj. Earnings Growth
21.82%
From $1.10 to $1.34 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.72 out of 5 stars

Medical Sector

257th out of 936 stocks

Drugs, Proprietaries, & Sundries Industry

5th out of 6 stocks

PETQ stock logo

About PetIQ Stock (NASDAQ:PETQ)

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats. It also provides OTC medications and supplies primarily within the flea and tick control, dog dewormers, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dog and cat treats, oral health solutions, stain and odor treatments, and pet nutritional supplements under the PetArmor®, Rocco & Roxie®, VetIQ®, Minties® and Sentry® brands. It provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PurLuv, Rocco & Roxie, Minties, Heart Shield Plus, and TruProfen brand names. In addition, the company operates veterinarian service platform through community clinics, pop-up locations, wellness centers, and permanent locations that offer cost effective and convenient veterinary wellness services, including diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene, and wellness checks; and provides veterinary care services. It operates through veterinarian, retail, and e-commerce channels. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho.

PETQ Stock Price History

PETQ Stock News Headlines

625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
3 Pet Stocks That Are Better Buys Than Chewy
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
See More Headlines
Receive PETQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetIQ and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/08/2024
Today
7/26/2024
Next Earnings (Confirmed)
8/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drugs, proprietaries, & sundries
Sub-Industry
Wholesale
Current Symbol
NASDAQ:PETQ
Fax
N/A
Employees
1,933
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$29.00
High Stock Price Target
$30.00
Low Stock Price Target
$28.00
Potential Upside/Downside
+32.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$2.13 million
Pretax Margin
0.67%

Debt

Sales & Book Value

Annual Sales
$1.10 billion
Cash Flow
$2.76 per share
Book Value
$7.58 per share

Miscellaneous

Free Float
26,890,000
Market Cap
$653.01 million
Optionable
Optionable
Beta
1.71
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

PETQ Stock Analysis - Frequently Asked Questions

How have PETQ shares performed this year?

PetIQ's stock was trading at $19.75 at the beginning of the year. Since then, PETQ stock has increased by 10.8% and is now trading at $21.89.
View the best growth stocks for 2024 here
.

How were PetIQ's earnings last quarter?

PetIQ, Inc. (NASDAQ:PETQ) posted its quarterly earnings results on Wednesday, May, 8th. The company reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.34 by $0.17. The firm earned $308.44 million during the quarter, compared to the consensus estimate of $302.16 million. PetIQ had a trailing twelve-month return on equity of 13.33% and a net margin of 0.66%.

What is Cord Christensen's approval rating as PetIQ's CEO?

10 employees have rated PetIQ Chief Executive Officer Cord Christensen on Glassdoor.com. Cord Christensen has an approval rating of 89% among the company's employees.

When did PetIQ IPO?

PetIQ (PETQ) raised $86 million in an IPO on Friday, July 21st 2017. The company issued 5,700,000 shares at $14.00-$16.00 per share. Jefferies and William Blair acted as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers.

Who are PetIQ's major shareholders?

Top institutional investors of PetIQ include Nepsis Inc. (3.03%), Tributary Capital Management LLC (1.74%), Assenagon Asset Management S.A. (0.48%) and Allspring Global Investments Holdings LLC (0.47%). Insiders that own company stock include Michael A Smith, Zvi Glasman, Allan Hall, Scott Huff, Susan Sholtis, Mccord Christensen and Robert Michael Herrman.
View institutional ownership trends
.

How do I buy shares of PetIQ?

Shares of PETQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of PetIQ own?

Based on aggregate information from My MarketBeat watchlists, some other companies that PetIQ investors own include Micron Technology (MU), NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Exelixis (EXEL), Intel (INTC) and CVS Health (CVS).

This page (NASDAQ:PETQ) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners